scholarly journals Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+)

Hepatology ◽  
2016 ◽  
Vol 63 (5) ◽  
pp. 1430-1441 ◽  
Author(s):  
Vincent Leroy ◽  
Peter Angus ◽  
Jean‐Pierre Bronowicki ◽  
Gregory J. Dore ◽  
Christophe Hezode ◽  
...  
Hepatology ◽  
2015 ◽  
Vol 61 (4) ◽  
pp. 1127-1135 ◽  
Author(s):  
David R. Nelson ◽  
James N. Cooper ◽  
Jacob P. Lalezari ◽  
Eric Lawitz ◽  
Paul J. Pockros ◽  
...  

2010 ◽  
Vol 82 (10) ◽  
pp. 1647-1654 ◽  
Author(s):  
Christine Larsen ◽  
Vanina Bousquet ◽  
Elisabeth Delarocque-Astagneau ◽  
Corinne Pioche ◽  
Françoise Roudot-Thoraval

2006 ◽  
Vol 78 (4) ◽  
pp. 452-458 ◽  
Author(s):  
Syed S. Hissar ◽  
Ankur Goyal ◽  
Manoj Kumar ◽  
Chandana Pandey ◽  
P.V. Suneetha ◽  
...  

2017 ◽  
Vol 37 (9) ◽  
pp. 1304-1313 ◽  
Author(s):  
Christophe Hézode ◽  
Piero L. Almasio ◽  
Stefan Bourgeois ◽  
Peter Buggisch ◽  
Ashley Brown ◽  
...  

2020 ◽  
Vol 133 (3) ◽  
pp. 253-261
Author(s):  
Nan Wu ◽  
Hui-Ying Rao ◽  
Wei-Bo Yang ◽  
Zhi-Liang Gao ◽  
Rui-Feng Yang ◽  
...  

Hepatology ◽  
2014 ◽  
Vol 60 (6) ◽  
pp. 1806-1808
Author(s):  
Daniel J. Felmlee ◽  
Catherine Schuster ◽  
Thomas F. Baumert

Sign in / Sign up

Export Citation Format

Share Document